Projects funded by the NCN
New amide derivatives of cinnamic acid as a carbonyl reductase inhibitors, which modulate the activity of doxorubicin - new perspective in cancer therapy
2016/21/D/NZ7/01546
Keywords:
chemotherapy doxorubicin cinnamic acid derivatives combined therapy
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ3_1: Cell biology
- NZ5_7: Human disease treatment
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny
woj. małopolskie
Principal investigator (from the host institution):
dr Paulina Koczurkiewicz-Adamczyk
Number of co-investigators in the project: 7
Call: SONATA 11 - announced on 2016-03-15
Amount awarded: 630 680 PLN
Project start date (Y-m-d): 2017-02-08
Project end date (Y-m-d): 2021-06-07
Project duration:: 52 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.